FIELD: biotechnology.
SUBSTANCE: invention relates to the use of the thiamine pyrophosphate kinase (TPK) gene or protein as a target for the treatment, prevention of Alzheimer's disease, in the screening of a medicinal product for the prevention or treatment of Alzheimer's disease, as a target for the production of a medicinal product for the prevention or treatment of the disease Alzheimer's, as well as in the construction of animal models of Alzheimer's disease. Also the following is disclosed: the use of a reagent that stimulates TPK protein kinase activity in the brain and/or the level of TPK protein expression in the brain in the preparation of a medicinal product for the treatment or prevention of Alzheimer's disease. The invention also relates to a medicinal product that contains the TKR gene or the TKR protein.
EFFECT: invention is effective for preventing or treating Alzheimer's disease.
25 cl, 13 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OBTAINING ANIMAL BEING DISTINCT AGAINST A MAN WITH A CERTAIN MUTATED GENE, METHOD FOR TESTING SUBSTANCE TO BE APPLIED FOR TREATING ALZHEIMER'S DISEASE (VARIANTS), PLASMID (VARIANTS), METHOD FOR OBTAINING PRIMARY CELL CULTURE OR SUBCULTIVATED CELL | 1999 |
|
RU2266002C2 |
TRANSGENIC ANIMALS HAVING MAIN ALZHEIMER'S DISEASE-RELATED DISORDERS | 2004 |
|
RU2373707C2 |
RODENTS WITH CONDITIONAL ACVR1 MUTANT ALLELES | 2014 |
|
RU2676961C2 |
MODEL OF PROGRESSIVE OSSIFICATION FIBRODYSPLASIYA IN RODENTS | 2019 |
|
RU2795136C2 |
TAU MODULATORS AND METHODS AND COMPOSITIONS FOR THEIR DELIVERY | 2017 |
|
RU2789459C2 |
METHOD FOR SCREENING SUBSTANCES HAVING WEIGHT CONTROL EFFECT | 2012 |
|
RU2603745C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING DEGENERATIVE BRAIN DISEASE COMPRISING GLYCINE TRANSPORTER AS ACTIVE INGREDIENT | 2021 |
|
RU2816256C1 |
METHODS AND COMPOSITIONS FOR TREATING AMYLOID DEPOSITS | 2013 |
|
RU2673484C2 |
ANIMALS OTHER THAN HUMANS CHARACTERIZED IN EXPANSION OF HEXANUCLEOTIDE REPEATS AT LOCUS C9orf72 | 2017 |
|
RU2760877C2 |
INVENTION OF PROTEIN PI4KIIIA AND RELATED MEMBRANE PROTEIN COMPLEX IN TREATMENT OF ALZHEIMER'S DISEASE | 2016 |
|
RU2724493C2 |
Authors
Dates
2023-09-28—Published
2020-07-29—Filed